VolitionRX Ltd (AMEX: VNRX)’s stock price has dropped by -4.02 in relation to previous closing price of 0.62. Nevertheless, the company has seen a loss of -13.52% in its stock price over the last five trading days. InvestorPlace reported 2024-01-18 that The International Monetary Fund believes that most of the impact from tighter money policies has already affected the U.S. economy, with the rest expected this year. Despite worries about a recession, the U.S. has shown resilience and strong growth since interest rates started going up in March 2022.
Is It Worth Investing in VolitionRX Ltd (AMEX: VNRX) Right Now?
The 36-month beta value for VNRX is at 1.38. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for VNRX is 60.56M, and currently, shorts hold a 0.82% of that float. The average trading volume for VNRX on April 19, 2024 was 115.05K shares.
VNRX’s Market Performance
The stock of VolitionRX Ltd (VNRX) has seen a -13.52% decrease in the past week, with a -25.95% drop in the past month, and a -40.33% fall in the past quarter. The volatility ratio for the week is 8.40%, and the volatility levels for the past 30 days are at 7.71% for VNRX. The simple moving average for the past 20 days is -17.32% for VNRX’s stock, with a -38.44% simple moving average for the past 200 days.
Analysts’ Opinion of VNRX
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see VNRX reach a price target of $7, previously predicting the price at $8. The rating they have provided for VNRX stocks is “Overweight” according to the report published on February 17th, 2022.
Cantor Fitzgerald gave a rating of “Overweight” to VNRX, setting the target price at $8 in the report published on March 10th of the previous year.
VNRX Trading at -33.34% from the 50-Day Moving Average
After a stumble in the market that brought VNRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.79% of loss for the given period.
Volatility was left at 7.71%, however, over the last 30 days, the volatility rate increased by 8.40%, as shares sank -17.82% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.59% lower at present.
During the last 5 trading sessions, VNRX fell by -12.42%, which changed the moving average for the period of 200-days by -58.34% in comparison to the 20-day moving average, which settled at $0.7100. In addition, VolitionRX Ltd saw -17.38% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VNRX starting from Eight Corp Ltd, who sale 20,000 shares at the price of $0.90 back on Jan 02 ’24. After this action, Eight Corp Ltd now owns 298,419 shares of VolitionRX Ltd, valued at $18,000 using the latest closing price.
Butera Salvatore Thomas, the CEO – Volition Veterinary of VolitionRX Ltd, purchase 10,000 shares at $0.83 during a trade that took place back on Dec 18 ’23, which means that Butera Salvatore Thomas is holding 99,350 shares at $8,300 based on the most recent closing price.
Stock Fundamentals for VNRX
Current profitability levels for the company are sitting at:
- -46.42 for the present operating margin
- -0.82 for the gross margin
The net margin for VolitionRX Ltd stands at -45.56. The total capital return value is set at 9.26. Equity return is now at value -5396.85, with -152.75 for asset returns.
Based on VolitionRX Ltd (VNRX), the company’s capital structure generated -1.87 points at debt to capital in total, while cash flow to debt ratio is standing at -3.57. The debt to equity ratio resting at -0.65. The interest coverage ratio of the stock is -162.38.
Currently, EBITDA for the company is -34.58 million with net debt to EBITDA at 0.43. When we switch over and look at the enterprise to sales, we see a ratio of 43.41. The receivables turnover for the company is 3.2for trailing twelve months and the total asset turnover is 0.03. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.69.
Conclusion
In conclusion, VolitionRX Ltd (VNRX) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
